After Trikafta: The Future of Modulators and Potential Effects on Treating CF

Mariah Hanley
Adult with CF

After Trikafta: The Future of Modulators and Potential Effects on Treating CF

Molly Pam
Person with CF

Wait – CFTR isn’t Just in the Lungs?!?

Cade Hovater
Adult with CF

Be the Voice in CF Research

Rachel Cravens
Parent of an Adult with CF

The Three R’s of CFTR: Restore, Repair, Replace
Beyond Modulators: Genetic Therapies on the Horizon
Closing

John Sheridan
Director of Research, CF Foundation

The Three R’s of CFTR: Restore, Repair, Replace

BIll Skach
Executive Vice President and Chief Scientific Officer, Cystic Fibrosis Foundation

The Three R’s of CFTR: Restore, Repair, Replace

Dara Riva
Parent of Children with CF and Director of Clinical Research Awards, Cystic Fibrosis Foundation

Beyond Modulators: Genetic Therapies on the Horizon

Sharon Cray
Parent of an Adult with CF

Beyond Modulators: Genetic Therapies on the Horizon

Julie Desch
Adult with CF

Changing CF Care in the Era of Trikafta: Are We There Yet?

Kathryn Sabadosa
Director of Quality Improvement & Innovation, CF Foundation

Therapeutic Approaches for Rare and Nonsense Mutations

Phil Thomas, MD
Ruth Harrell Professor of Medical Research at the University of Texas Southwestern Medical Center and Senior Scientific Advisor at the CFF Laboratory

CF 101: Decoding CFTR Genetics to Transform Treatment

George (Marty) Solomon
Director